These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24600432)

  • 1. Levetiracetam Differentially Alters CD95 Expression of Neuronal Cells and the Mitochondrial Membrane Potential of Immune and Neuronal Cells in vitro.
    Rogers SK; Shapiro LA; Tobin RP; Tow B; Zuzek A; Mukherjee S; Newell-Rogers MK
    Front Neurol; 2014; 5():17. PubMed ID: 24600432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: a review of its use in epilepsy.
    Lyseng-Williamson KA
    Drugs; 2011 Mar; 71(4):489-514. PubMed ID: 21395360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spotlight on levetiracetam in epilepsy.
    Lyseng-Williamson KA
    CNS Drugs; 2011 Oct; 25(10):901-5. PubMed ID: 21936590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam as an alternative to phenytoin for second-line emergency treatment of children with convulsive status epilepticus: the EcLiPSE RCT.
    Appleton RE; Rainford NE; Gamble C; Messahel S; Humphreys A; Hickey H; Woolfall K; Roper L; Noblet J; Lee E; Potter S; Tate P; Al Najjar N; Iyer A; Evans V; Lyttle MD
    Health Technol Assess; 2020 Nov; 24(58):1-96. PubMed ID: 33190679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.
    Matagne A; Margineanu DG; Kenda B; Michel P; Klitgaard H
    Br J Pharmacol; 2008 Aug; 154(8):1662-71. PubMed ID: 18500360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study.
    Trimboli M; Russo E; Mumoli L; Tripepi G; Fortunato F; Mastroianni G; Abate F; De Sarro G; Gambardella A; Labate A
    Eur J Neurol; 2018 Apr; 25(4):666-671. PubMed ID: 29322654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levetiracetam and N-Cadherin Antibody Alleviate Brain Pathology Without Reducing Early Epilepsy Development After Focal Non-convulsive Status Epilepticus in Rats.
    Avdic U; Ahl M; Andersson M; Ekdahl CT
    Front Neurol; 2021; 12():630154. PubMed ID: 33716930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam monotherapy for the treatment of infants with epilepsy.
    Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
    Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interaction study of Ocimum sanctum L. and levetiracetam in pentylenetetrazole kindling model of epilepsy.
    Sarangi SC; Pattnaik SS; Katyal J; Kaleekal T; Dinda AK
    J Ethnopharmacol; 2020 Mar; 249():112389. PubMed ID: 31739106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.
    Jones KE; Puccio AM; Harshman KJ; Falcione B; Benedict N; Jankowitz BT; Stippler M; Fischer M; Sauber-Schatz EK; Fabio A; Darby JM; Okonkwo DO
    Neurosurg Focus; 2008 Oct; 25(4):E3. PubMed ID: 18828701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in childhood epilepsy.
    Verrotti A; D'Adamo E; Parisi P; Chiarelli F; Curatolo P
    Paediatr Drugs; 2010 Jun; 12(3):177-86. PubMed ID: 20486734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
    Chaisewikul R; Privitera MD; Hutton JL; Marson AG
    Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam.
    Nash EM; Sangha KS
    Am J Health Syst Pharm; 2001 Jul; 58(13):1195-9. PubMed ID: 11449876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam: its use in partial-onset seizure.
    Pellock JM; Sankar R
    Expert Rev Neurother; 2003 Nov; 3(6):751-60. PubMed ID: 19810878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H; Matagne A; Gobert J; Wülfert E
    Eur J Pharmacol; 1998 Jul; 353(2-3):191-206. PubMed ID: 9726649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effects of levetiracetam and simvastatin on pilocarpine-induced epilepsy in rat models].
    Li MQ; Zhang WW; Chen T; Liu L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):201-4. PubMed ID: 25924429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between efficacy of levetiracetam and serum levels among children with refractory epilepsy.
    Sheinberg R; Heyman E; Dagan Z; Youngster I; Kohn E; Gandelman-Marton R; Berkovitch M
    Pediatr Neurol; 2015 Jun; 52(6):624-8. PubMed ID: 25791893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levetiracetam attenuates hippocampal expression of synaptic plasticity-related immediate early and late response genes in amygdala-kindled rats.
    Christensen KV; Leffers H; Watson WP; Sánchez C; Kallunki P; Egebjerg J
    BMC Neurosci; 2010 Jan; 11():9. PubMed ID: 20105316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel antiepileptic drug levetiracetam (ucb L059) induces alterations in GABA metabolism and turnover in discrete areas of rat brain and reduces neuronal activity in substantia nigra pars reticulata.
    Löscher W; Hönack D; Bloms-Funke P
    Brain Res; 1996 Oct; 735(2):208-16. PubMed ID: 8911659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.